![Gradient Dissent: Conversations on AI artwork](https://is5-ssl.mzstatic.com/image/thumb/Podcasts123/v4/1b/4d/c0/1b4dc0e9-4ae7-2884-093a-dec0dcb8077d/mza_4871585294732629178.jpg/100x100bb.jpg)
Jeff Hammerbacher — From data science to biomedicine
Gradient Dissent: Conversations on AI
English - August 26, 2021 13:00 - 56 minutes - 52.3 MBTechnology Homepage Download Google Podcasts Overcast Castro Pocket Casts RSS feed
Jeff talks about building Facebook's early data team, founding Cloudera, and transitioning into biomedicine with Hammer Lab and Related Sciences.
(Read more: http://wandb.me/gd-jeff-hammerbacher)
---
Jeff Hammerbacher is a scientist, software developer, entrepreneur, and investor. Jeff's current work focuses on drug discovery at Related Sciences, a biotech venture creation firm that he co-founded in 2020.
Prior to his work at Related Sciences, Jeff was the Principal Investigator of Hammer Lab, a founder and the Chief Scientist of Cloudera, an Entrepreneur-in-Residence at Accel, and the manager of the Data team at Facebook.
---
Follow Gradient Dissent on Twitter: https://twitter.com/weights_biases
---
0:00 Sneak peek, intro
1:13 The start of Facebook's data science team
6:53 Facebook's early tech stack
14:20 Early growth strategies at Facebook
17:37 The origin story of Cloudera
24:51 Cloudera's success, in retrospect
31:05 Jeff's transition into biomedicine
38:38 Immune checkpoint blockade in cancer therapy
48:55 Data and techniques for biomedicine
53:00 Why Jeff created Related Sciences
56:32 Outro